Compier Aggregate Reports

Home / Innovation / Compier Aggregate Reports

Synchronize and Simplify Drug Safety Aggregate Reporting

Marketing Authorization Holders (MAH) are expected to prepare and submit aggregate safety reports to regional and global regulatory bodies to account for the medicine’s safety profile over an extended period of time. These periodic reports shall be used for assessing the risk-benefit of the product and taking appropriate action where new risks or changes to known risks are identified.

Compier Aggregate Reports

With Compier Aggregate Reports, pharma companies can automate the complete regulatory reporting lifecycle management from pre-approval to post-approval of medicinal products.

It facilitates digital authoring of different types of aggregate reports, online completion of collaborative review and creating a reporting schedule for different regulatory submissions.


Key Product Features

  • Report Schedule Management:Create and Manage global reporting schedules/timetables with calendar trackers.
  • Predefined Templates – Organizations can leverage predefined Aggregate Report templates for various types of reports such as PADER, PSUR, PBRER, DSUR, CTPR or can define templates as per business requirements
  • Digital Authoring: Author reports within Compier without any dependency on third party apps
  • Collaborative Review: Schedule, initiate, and complete report content review with multiple teams and reviewers at the same time
  • Workflow driven activities: Define and configure workflows from scheduling, authoring till submission
  • Regulatory tracking: Acknowledgements received for each submission and amendment can be tracked and reported
  • Access Control: Define controls to who can view, edit, review, approve aggregate reports
  • Version Controlled: Access latest version of aggregate report with archived older versions
  • Auto Update Rules: Auto update modules, templates, schedules and aggregate report based on pre-defined rules
  • Sharing Aggregate Reports: Allows sharing in various formats such as word, PDF, weblink, etc. through various channels
  • Alerts & Notifications: Stay informed on workflow tasks assignment, workflow tasks and related activity updates
  • Insights & Analytics: Ready to use and extendable dashboards, data listings and performance indicators

Seamless Integrations with various source systems to enable 100% process automation

  • Drug Safety Database
  • Signal Management System
  • Clinical Systems
  • Quality Management System
  • Literature Screening
  • Other modules of Compier
  • Other organization wide operational data source systems

Aggregate Reporting is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

Business Analysis

How Do we Deliver

Our technology platform, process accelerators and subject matter expertise enable you with a comprehensive solution to digitalize and automate the entire compliance associated with aggregate reporting. Our solutions are flexible, modular and can be deployed by MAH, QPPV office and CRO companies globally or at local entities.

New Insights

Food & Nutraceuticals: How Companies can Prove Health Value with Clinical Trials

What are Food and Nutraceuticals? ‘Nutraceuticals’ is a composite term of ‘nutrition’ and ‘pharmaceutical’. They are a blend of products that possess both nutritional as well as medicinal value. They are designed to improve physical health, boost immunity, and deal with stress and increase longevity. Nutraceutical products play a significant role in maintaining normal physiological [...]

Best Practices for Signal Management in Pharmacovigilance

Pharmacovigilance involves the collection, detection, assessment, and monitoring of data on Adverse Drug Reactions (ADRs) which must be evaluated to derive vital safety information. Signal detection involves monitoring the adverse reaction data for patterns that suggest new safety information. Safety signals can be detected from an extensive range of sources, such as spontaneous reports, clinical [...]

Enabling eSource in Clinical Studies to Optimize Trial Quality

Source data is all information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. The electronic data source or eSource is the data that is initially recorded in electronic format in this process. Biopharma and [...]

Get in Touch with Us